455 related articles for article (PubMed ID: 22446114)
1. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
2. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.
Choe YJ; Cho H; Kim SN; Bae GR; Lee JK
Vaccine; 2011 Oct; 29(44):7727-32. PubMed ID: 21827815
[TBL] [Abstract][Full Text] [Related]
3. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing].
Miao L; Lu L; Wu J; Suo LD; Liu DL; Sun MP; Pang XH; Deng Y; Wang XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct; 44(10):884-7. PubMed ID: 21176517
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
[TBL] [Abstract][Full Text] [Related]
7. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
Lawrence GL; Boyd I; McIntyre PB; Isaacs D
Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
Choe YJ; Cho H; Bae GR; Lee JK
Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
[TBL] [Abstract][Full Text] [Related]
9. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
Pahud BA; Williams SE; Dekker CL; Halsey N; Larussa P; Baxter RP; Klein NP; Marchant CD; Sparks RC; Jakob K; Aukes L; Swope S; Barnett E; Lewis P; Berger M; Dreskin SC; Donofrio PD; Sejvar JJ; Slade BA; Gidudu J; Vellozzi C; Edwards KM
Pediatr Infect Dis J; 2013 Feb; 32(2):163-8. PubMed ID: 23334340
[TBL] [Abstract][Full Text] [Related]
11. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
Fu C; Xu J; Tan H; Wang M
Pediatr Infect Dis J; 2011 Jul; 30(7):631-2. PubMed ID: 21673552
[No Abstract] [Full Text] [Related]
12. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
[TBL] [Abstract][Full Text] [Related]
13. [Safety and epidemiological effects of the first China-made mass A (H1N1) influenza vaccination].
Ji WY; Lu L; Lü M; Miao L; Gao T; Huang RG; Suo LD; Liu DL; Ma R; Yu R; Zhangzhu JZ; Liu WX; Zeng Y; Li XM; Wu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):481-4. PubMed ID: 21163019
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
[TBL] [Abstract][Full Text] [Related]
15. 2009-2010 novel influenza A (H1N1) vaccination coverage in the Republic of Korea.
Lee YK; Kwon Y; Kim DW; Song KM; Cho H; Kim CH; Go UY; Bae GR; Lee JK
Am J Infect Control; 2012 Jun; 40(5):481-3. PubMed ID: 21868134
[TBL] [Abstract][Full Text] [Related]
16. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
17. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
18. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
[TBL] [Abstract][Full Text] [Related]
19. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
[TBL] [Abstract][Full Text] [Related]
20. An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one.
Candela S; Pergolizzi S; Ragni P; Cavuto S; Nobilio L; Di Mario S; Dragosevic V; Groth N; Magrini N;
Vaccine; 2013 Feb; 31(10):1431-7. PubMed ID: 22766247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
